Author

Serdar Durdağı

Observed name: Durdağı, Serdar

Institutions: Bahçeşehir University, Biruni University

Observed institutions: Bahçeşehir University, Biruni University

ORCID: 0000-0002-0426-0905

Observed ORCID: 0000-0002-0426-0905

OpenAlex ID: A5125592134

Computational discovery and preclinical validation of a novel nanodrug eEF2 kinase inhibitor for suppression of tumor growth in triple-negative breast cancer by induction of ferroptosis and apoptosis

2026 · Ferah Comert Onder, Nermin Kahraman, et al. · International Journal of Biological Macromolecules · 2

Advancing Accurate Quantification of Protein‐Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL‐2 as a Model System

2026 · Bircan Dinc, Berna Dogan, et al. · ChemMedChem · 2

Differential conservation analysis identifies residues defining constitutive internalization in beta-adrenergic receptors

2026 · Abigail Rose Walker, Berkay Selçuk, et al. · iScience · 1

Triazole-substituted pyrazole–pyrimidine hybrids as anticancer agents: synthesis, cytotoxicity, apoptosis mechanisms, and JAB1-targeted structure-based design

2026 · Fatma Albayrak Halac, Zeynep Tugay Tulumcu, et al. · Bioorganic Chemistry · 1

Novel VARS1 variants define new clinical and molecular subtypes of a rare neurodevelopmental syndrome

2026 · Busra Aynekin, Tracy Lau, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 1

Corrigendum to “Novel VARS1 variants define new clinical and molecular subtypes of a rare neurodevelopmental syndrome” [Biochim. Biophys. Acta Mol. Basis Dis. 1872 (2026)/168184]

2026 · Busra Aynekin, Tracy Lau, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Machine learning-driven discovery of potent isocitrate dehydrogenase 1 mutant inhibitors from ultralarge ligand libraries for targeting malignant glioma

2026 · Mehreen Zaka, Fareed Asaad, et al. · Journal of Pharmacology and Experimental Therapeutics

eEF-2K Enzimini İnhibe Etme Potansiyeline Sahip Yeni Moleküllerin Sentezi

2021 · Ay, Mehmet, Cömert Önder, Ferah, et al. · Çanakkale Onsekiz Mart University AVESIS

Novel coumarin-chalcone hybrids as effective eEF2K inihibitors for the treatment of triple negative breast cancer: In silico, synthesis and in vitro studies

2021 · Ay, Mehmet, Cömert Önder, Ferah, et al. · Çanakkale Onsekiz Mart University AVESIS

Nitrobenzamide Derivatives as iNOS Inhibitors AlsoPromotes Nrf2 Mediated Cytoprotective Response: inVitro and in Silico Approaches

2018 · TÜMER , TUĞBA, Cömert Önder, FERAH, et al. · Çanakkale Onsekiz Mart University AVESIS

Nitrobenzamide Derivatives as iNOS Inhibitors Also Promotes Nrf2 Mediated Cytoprotective Response: In Vitro and In Silico Approaches

2018 · TÜMER , TUĞBA, YILMAZ, YAKUP BERKAY, et al. · Çanakkale Onsekiz Mart University AVESIS

Nitrobenzamide Derivatives as iNOS Inhibitors Also Promotes Nrf2 Mediated Cytoprotective Response: in Vitro and in Silico Approaches

2018 · Cömert Önder, FERAH, Tümer , Tuğba, et al. · Çanakkale Onsekiz Mart University AVESIS

Nitrobenzamide Derivatives as iNOS Inhibitors Also Promotes Nrf2 Mediated Cytoprotective Response: in Vitro and in Silico Approaches (Oral presentation)

2018 · Tümer, Tuğba, Ay, Mehmet, et al. · Çanakkale Onsekiz Mart University AVESIS

Works count: 13

Citation count: 7

H-index: 2

I10-index: